Pharmlog Pharma Logistik
Pharmlog Pharma Logistik, commonly referred to as Pharmlog, is a leading provider of pharmaceutical logistics solutions headquartered in Germany, with significant operations across Europe. Established in 2004, the company has rapidly evolved to become a key player in the pharmaceutical and healthcare logistics industry, specialising in temperature-controlled transport and warehousing. Pharmlog offers a range of core services, including the distribution of pharmaceuticals, clinical trial logistics, and customised supply chain solutions. Their commitment to quality and compliance with stringent regulatory standards sets them apart in the market. With a focus on innovation and efficiency, Pharmlog has achieved notable milestones, reinforcing its position as a trusted partner for pharmaceutical companies seeking reliable logistics support.
DitchCarbon Score
How does Pharmlog Pharma Logistik's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmlog Pharma Logistik's score of 32 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmlog Pharma Logistik's reported carbon emissions
In 2022, PharmLog Pharma Logistik reported total greenhouse gas emissions of approximately 6.7 million tonnes CO2e. This figure includes 1.4 million tonnes from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 242,000 tonnes from Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling. The company also recorded significant Scope 3 emissions, estimated at about 6.6 million tonnes CO2e, which encompass indirect emissions from the value chain, including purchased goods and services. PharmLog has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions by 46% by 2030, using 2019 as the baseline year. This target has been approved by the Science Based Targets initiative (SBTi) and aligns with the goal of limiting global warming to 1.5°C. The company is also committed to measuring and reducing its Scope 3 emissions, reflecting a comprehensive approach to tackling its overall carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 332,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 304,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 348,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmlog Pharma Logistik is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
